HCPCS code J0637 — Caspofungin acetate. Status: Active. Effective Jan 1, 2024. Source: CMS HCPCS Level II.

J0637

Active

Caspofungin acetate

Injection, caspofungin acetate, 5 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2024
Code type: alphanumeric
OPPS Status: N — Items / services packaged into APC rates

MUE — Medically Unlikely Edits

Maximum units of J0637 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 0
Outpatient Hospital 20
Practitioner Services 20

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00006-3822-10 Cancidas
00006-3823-10 Cancidas
00781-3421-94 Caspofungin Acetate
00781-3423-94 Caspofungin Acetate
25021-0194-10 Caspofungin Acetate
25021-0195-10 Caspofungin Acetate
59923-0613-70 Caspofungin Acetate
59923-0614-50 Caspofungin Acetate
63323-0356-10 Caspofungin Acetate
63323-0358-10 Caspofungin Acetate
70860-0106-10 Caspofungin Acetate
70860-0107-10 Caspofungin Acetate
72266-0106-01 Caspofungin
72266-0107-01 Caspofungin
72611-0700-01 Caspofungin

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q1
    Caspofungin acetate